Assignee
ONYX PHARMACEUTICALS
US·6 granted patents·3 pending applications·157 citations·filing 1996–2006
Top patents by PatentIndex Score
9 records- 0196US6187799B1Inhibition of raf kinase activity using aryl ureasONYX PHARMACEUTICALS·Filed 1998·Granted Feb 13, 2001·118 cites·18 claims
- 0266US5856132AG-beta-gamma regulated phosphatidylinositol-3' kinaseONYX PHARMACEUTICALS·Filed 1997·Granted Jan 5, 1999·15 cites·32 claims
- 0361US2006292122A1Adenoviral vectors for treating diseasesONYX PHARMACEUTICALS·Filed 2006·Application pending·0 cites
- 0461US2006257370A1Adenoviral vectors for treating diseasesONYX PHARMACEUTICALS·Filed 2006·Application pending·0 cites
- 0561US2006257371A1Adenoviral vectors for treating diseasesONYX PHARMACEUTICALS·Filed 2006·Application pending·0 cites
- 0652US5869271AG-beta-gamma regulated phosphatidylinositol-3' kinaseONYX PHARMACEUTICALS·Filed 1997·Granted Feb 9, 1999·7 cites·6 claims
- 0751US5859201AG-beta-gamma regulated phosphatidylinositol-3' kinaseONYX PHARMACEUTICALS·Filed 1997·Granted Jan 12, 1999·6 cites·13 claims
- 0850US5874273AG-beta-gamma regulated phosphatidylinositol-3' kinaseONYX PHARMACEUTICALS·Filed 1996·Granted Feb 23, 1999·7 cites·33 claims
- 0945US5856133AG-beta-gamma regulated phosphatidylinositol-3'kinaseONYX PHARMACEUTICALS·Filed 1997·Granted Jan 5, 1999·4 cites·6 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →